½ÃÀ庸°í¼­
»óǰÄÚµå
1193153

¼¼°èÀÇ ¼ÒÇÁÆ®Á© ĸ½¶ ½ÃÀå : À¯Çüº°, ¿ëµµº°, À¯Åë ä³Îº°-±âȸ ºÐ¼® ¹× »ê¾÷ ¿¹Ãø(2021-2031³â)

Softgel Capsules Market By Type, By Application, By Distribution Channel : Global Opportunity Analysis and Industry Forecast, 2021-2031

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Allied Market Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 265 Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼ÒÇÁÆ®Á© ĸ½¶(Softgel Capsules) ½ÃÀåÀº 2021³â¿¡ 44¾ï 2,423¸¸ ´Þ·¯¿´À¸¸ç, 2031³â±îÁö 74¾ï 9,907¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¶Ç, 2022³âºÎÅÍ 2031³â±îÁö ¿¹Ãø ±â°£ µ¿¾È CAGRÀº 5.4%¸¦ ±â·ÏÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼ÒÇÁÆ®Á© ¶Ç´Â ¼ÒÇÁÆ® Á©¶óƾ ĸ½¶Àº ¾×ü ¶Ç´Â ¹Ý°íü Áß½É(³»ºÎ ÃæÀü¹°)À» µÑ·¯½Î°í ÀÖ´Â °íü ĸ½¶(¿ÜÇÇ)ÀÔ´Ï´Ù. Ȱ¼º ¼ººÐÀº ¿ÜÇÇ, ³»ºÎ ÃæÀü¹° ¶Ç´Â µÑ ´Ù¿¡ ÅëÇÕµÉ ¼ö ÀÖ½À´Ï´Ù. ¼ÒÇÁÆ®Á©Àº ĸ½¶°ú À¯»çÇÑ °æ±¸¿ë ÀǾàǰ Á¦ÇüÀÔ´Ï´Ù. ¼ÒÇÁÆ®Á© ĸ½¶¿¡´Â Á©¶óƾ ¼ÒÇÁÆ®Á© ĸ½¶°ú º£ÁöÅ׸®¾ð ¼ÒÇÁÆ®Á© ĸ½¶ÀÇ µÎ °¡Áö À¯ÇüÀÌ ÀÖ½À´Ï´Ù. Á©¶óƾ ¼ÒÇÁÆ®Á©Àº ÀϹÝÀûÀ¸·Î Á©¶óƾÀ¸·Î ¸¸µé¾îÁö¸ç ¾×ü ¶Ç´Â À¯¼º ¼ººÐÀ¸·Î ±¸¼ºµÈ ´ÜÀÏ Ä¸½¶ÀÔ´Ï´Ù. ¹Ý¸é¿¡ º£ÁöÅ׸®¾ð ¼ÒÇÁÆ®Á© ĸ½¶Àº ĸ½¶ ÇüÅ·ΠÁ¦°øµÇ´Â °æ±¸¿ë ÀǾàǰ ¹× ¿µ¾ç º¸ÃæÁ¦ÀÔ´Ï´Ù. ÀüºÐ, Ç®·ê¶õ, ¼¿·ê·Î¿À½º(È÷µå·Ï½ÃÇÁ·ÎÇÊ¸ÞÆ¿¼¿·ê·Î¿À½º)·Î ¸¸µé¾îÁý´Ï´Ù.

¼ÒÇÁÆ®Á© ĸ½¶ ½ÃÀåÀÇ ¼ºÀåÀº ÁÖ·Î °Ç°­¿¡ °ü½ÉÀÌ ¸¹Àº »ç¶÷µéÀÇ ¼ö Áõ°¡¿Í Á¦¾à »ê¾÷ÀÇ Çõ½Å ¼ºÀåÀ¸·Î ÀÎÇØ ¼ÒÇÁÆ®Á© ĸ½¶¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÔ¿¡ µû¶ó ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÀüÀÚ »ó°Å·¡ »ê¾÷ÀÇ ±Þ¼ÓÇÑ ¹ßÀü°ú ÀÇ·á¿¡ ´ëÇÑ Á¤ºÎ ÁöÃâ Áõ°¡µµ ½ÃÀå ¼ºÀåÀÇ ¿äÀÎÀÔ´Ï´Ù.

±×·¯³ª Àú°³¹ß±¹ÀÇ ¼ÒÇÁÆ® Á© ĸ½¶¿¡ ´ëÇÑ ¼ö¿ä ºÎÁ·°ú º£ÁöÅ׸®¾ð ¼ÒÇÁÆ®Á© ĸ½¶ÀÇ ¸·´ëÇÑ ºñ¿ëÀº ½ÃÀå ¼ºÀåÀ» ÀúÇØÇÏ´Â ¸î °¡Áö Á¦¾à Áß ÇϳªÀÔ´Ï´Ù. ¹Ý¸é¿¡ ½ÅÈï ½ÃÀåÀÇ ³ôÀº ¼ºÀå ÀáÀç·Â°ú ºñ°Ç Àα¸ÀÇ Áõ°¡´Â ¿¹Ãø ±â°£ µ¿¾È ½ÃÀå ¼ºÀåÀ» À§ÇÑ ¼öÀͼº ÀÖ´Â ±âȸ¸¦ Á¦°ø ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼Ò°³

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå °³¿ä

  • ½ÃÀå Á¤ÀÇ¿Í ¹üÀ§
  • ÁÖ¿ä Á¶»ç °á°ú
    • ÁÖ¿ä ÅõÀÚ Æ÷ÄÏ
  • Porter¡¯s Five Forces
  • ÁÖ¿ä ±â¾÷ÀÇ Æ÷Áö¼Å´×
  • ½ÃÀå ¿ªÇÐ
    • ÃËÁø ¿äÀÎ
    • ¾ïÁ¦ ¿äÀÎ
    • ±âȸ
  • COVID-19 ¿µÇ⠺м®
  • ƯÇã »óȲ

Á¦4Àå ¼ÒÇÁÆ®Á© ĸ½¶ ½ÃÀå : À¯Çüº°

  • °³¿ä
    • ½ÃÀå ±Ô¸ð ¹× ¿¹Ãø
  • Á©¶óƾ ¼ÒÇÁÆ®Á© ĸ½¶
    • ÁÖ¿ä ½ÃÀå µ¿Çâ, ¼ºÀå ¿äÀÎ, ±âȸ
    • ½ÃÀå ±Ô¸ð¡¤¿¹Ãø : Áö¿ªº°
    • ½ÃÀå Á¡À¯À² ºÐ¼® : ±¹°¡º°
  • ºñÁ©¶óƾ ¼ÒÇÁÆ®Á© ĸ½¶
    • ÁÖ¿ä ½ÃÀå µ¿Çâ, ¼ºÀå ¿äÀÎ, ±âȸ
    • ½ÃÀå ±Ô¸ð¡¤¿¹Ãø : Áö¿ªº°
    • ½ÃÀå Á¡À¯À² ºÐ¼® : ±¹°¡º°
    • ºñÁ©¶óƾ ¼ÒÇÁÆ®Á© ĸ½¶ ½ÃÀå : ¿ø·áº°
      • ÀüºÐ ½ÃÀå ±Ô¸ð ¹× ¿¹Ãø : Áö¿ªº°
      • ¼¿·ê·Î¿À½º ½ÃÀå ±Ô¸ð¡¤¿¹Ãø : Áö¿ªº°
      • Ç®·ç¶õ ½ÃÀå ±Ô¸ð¡¤¿¹Ãø : Áö¿ªº°

Á¦5Àå ¼ÒÇÁÆ®Á© ĸ½¶ ½ÃÀå : ¿ëµµº°

  • °³¿ä
    • ½ÃÀå ±Ô¸ð¡¤¿¹Ãø
  • ÀǾàǰ
    • ÁÖ¿ä ½ÃÀå µ¿Çâ, ¼ºÀå ¿äÀÎ, ±âȸ
    • ½ÃÀå ±Ô¸ð¡¤¿¹Ãø : Áö¿ªº°
    • ½ÃÀå Á¡À¯À² ºÐ¼® : ±¹°¡º°
  • °Ç°­ º¸Á¶ ½Äǰ
    • ÁÖ¿ä ½ÃÀå µ¿Çâ, ¼ºÀå ¿äÀÎ, ±âȸ
    • ½ÃÀå ±Ô¸ð¡¤¿¹Ãø : Áö¿ªº°
    • ½ÃÀå Á¡À¯À² ºÐ¼® : ±¹°¡º°
  • È­Àåǰ
    • ÁÖ¿ä ½ÃÀå µ¿Çâ, ¼ºÀå ¿äÀÎ, ±âȸ
    • ½ÃÀå ±Ô¸ð¡¤¿¹Ãø : Áö¿ªº°
    • ½ÃÀå Á¡À¯À² ºÐ¼® : ±¹°¡º°

Á¦6Àå ¼ÒÇÁÆ®Á© ĸ½¶ ½ÃÀå : À¯Åë ä³Îº°

  • °³¿ä
    • ½ÃÀå ±Ô¸ð¡¤¿¹Ãø
  • ½´ÆÛ¸¶ÄÏ, ÇÏÀÌÆÛ¸¶ÄÏ
    • ÁÖ¿ä ½ÃÀå µ¿Çâ, ¼ºÀå ¿äÀÎ, ±âȸ
    • ½ÃÀå ±Ô¸ð¡¤¿¹Ãø : Áö¿ªº°
    • ½ÃÀå Á¡À¯À² ºÐ¼® : ±¹°¡º°
  • ¾à±¹¡¤¾à±¹
    • ÁÖ¿ä ½ÃÀå µ¿Çâ, ¼ºÀå ¿äÀÎ, ±âȸ
    • ½ÃÀå ±Ô¸ð¡¤¿¹Ãø : Áö¿ªº°
    • ½ÃÀå Á¡À¯À² ºÐ¼® : ±¹°¡º°
  • ¿Â¶óÀÎ Á¦°øÀÚ
    • ÁÖ¿ä ½ÃÀå µ¿Çâ, ¼ºÀå ¿äÀÎ, ±âȸ
    • ½ÃÀå ±Ô¸ð¡¤¿¹Ãø : Áö¿ªº°
    • ½ÃÀå Á¡À¯À² ºÐ¼® : ±¹°¡º°

Á¦7Àå ¼ÒÇÁÆ®Á© ĸ½¶ ½ÃÀå : Áö¿ªº°

  • °³¿ä
    • ½ÃÀå ±Ô¸ð¡¤¿¹Ãø
  • ºÏ¹Ì
    • ÁÖ¿ä µ¿Çâ°ú ±âȸ
    • ºÏ¹ÌÀÇ ½ÃÀå ±Ô¸ð¡¤¿¹Ãø : À¯Çüº°
      • ºÏ¹ÌÀÇ ºñÁ©¶óƾ ¼ÒÇÁÆ®Á© ĸ½¶ ½ÃÀå : ¿ø·áº°
    • ºÏ¹ÌÀÇ ½ÃÀå ±Ô¸ð¡¤¿¹Ãø : ¿ëµµº°
    • ºÏ¹ÌÀÇ ½ÃÀå ±Ô¸ð¡¤¿¹Ãø : À¯Åë ä³Îº°
    • ºÏ¹ÌÀÇ ½ÃÀå ±Ô¸ð¡¤¿¹Ãø : ±¹°¡º°
      • ¹Ì±¹
      • ij³ª´Ù
      • ¸ß½ÃÄÚ
  • À¯·´
    • ÁÖ¿ä µ¿Çâ°ú ±âȸ
    • À¯·´ÀÇ ½ÃÀå ±Ô¸ð¡¤¿¹Ãø : À¯Çüº°
      • À¯·´ÀÇ ºñÁ©¶óƾ ¼ÒÇÁÆ®Á© ĸ½¶ ½ÃÀå : ¿ø·áº°
    • À¯·´ÀÇ ½ÃÀå ±Ô¸ð¡¤¿¹Ãø : ¿ëµµº°
    • À¯·´ÀÇ ½ÃÀå ±Ô¸ð¡¤¿¹Ãø : À¯Åë ä³Îº°
    • À¯·´ÀÇ ½ÃÀå ±Ô¸ð¡¤¿¹Ãø : ±¹°¡º°
      • µ¶ÀÏ
      • ÇÁ¶û½º
      • ¿µ±¹
      • ÀÌÅ»¸®¾Æ
      • ½ºÆäÀÎ
      • ±âŸ À¯·´ Áö¿ª
  • ¾Æ½Ã¾Æ ÅÂÆò¾ç Áö¿ª
    • ÁÖ¿ä µ¿Çâ°ú ±âȸ
    • ¾Æ½Ã¾Æ ÅÂÆò¾ç Áö¿ª ½ÃÀå ±Ô¸ð¡¤¿¹Ãø : À¯Çüº°
      • ¾Æ½Ã¾Æ ÅÂÆò¾ç Áö¿ªÀÇ ºñÁ©¶óƾ ¼ÒÇÁÆ®Á© ĸ½¶ ½ÃÀå : ¿ø·áº°
    • ¾Æ½Ã¾Æ ÅÂÆò¾ç Áö¿ª ½ÃÀå ±Ô¸ð¡¤¿¹Ãø : ¿ëµµº°
    • ¾Æ½Ã¾Æ ÅÂÆò¾ç Áö¿ª ½ÃÀå ±Ô¸ð¡¤¿¹Ãø : À¯Åë ä³Îº°
    • ¾Æ½Ã¾Æ ÅÂÆò¾ç Áö¿ª ½ÃÀå ±Ô¸ð¡¤¿¹Ãø : ±¹°¡º°
      • ÀϺ»
      • Áß±¹
      • Àεµ
      • È£ÁÖ
      • Çѱ¹
      • ±âŸ ¾Æ½Ã¾Æ ÅÂÆò¾ç Áö¿ª
  • LAMEA
    • ÁÖ¿ä µ¿Çâ°ú ±âȸ
    • LAMEA ½ÃÀå ±Ô¸ð¡¤¿¹Ãø : À¯Çüº°
      • LAMEA ºñÁ©¶óƾ ¼ÒÇÁÆ®Á© ĸ½¶ ½ÃÀå : ¿ø·áº°
    • LAMEA ½ÃÀå ±Ô¸ð¡¤¿¹Ãø : ¿ëµµº°
    • LAMEA ½ÃÀå ±Ô¸ð¡¤¿¹Ãø : À¯Åë ä³Îº°
    • LAMEA ½ÃÀå ±Ô¸ð¡¤¿¹Ãø : ±¹°¡º°
      • ºê¶óÁú
      • »ç¿ìµð ¾Æ¶óºñ¾Æ
      • ³²¾ÆÇÁ¸®Ä« Áö¿ªÀÇ °øÈ­±¹
      • ±âŸ LAMEA Áö¿ª

Á¦8Àå ±â¾÷ Á¤¼¼

  • ¼Ò°³
  • ÁÖ¿ä ¼º°ø Àü·«
  • ÁÖ¿ä 10°³»çÀÇ Á¦Ç° ¸ÅÇÎ
  • °æÀï ´ë½Ãº¸µå
  • °æÇÕÀÇ È÷Æ® ¸Ê
  • ÁÖ¿ä ¹ßÀü

Á¦9Àå ±â¾÷ °³¿ä

  • Aenova Group
  • Best Formulations, Inc.
  • Captek Softgel International, Inc.
  • Catalant, Inc.
  • DCC Plc.(Eurocaps)
  • Procaps Groups
  • Robinson Pharma, Inc.
  • Lyfe Group(Caps Canada)
  • Sirio Pharma Co. (Ayanda)
  • Thermofisher Scientific, Inc(Patheon)
LSH 23.03.13

The global softgel capsules market was valued at $4,424.23 million in 2021, and is projected to reach $7,499.07 million by 2031, registering a CAGR of 5.4% from 2022 to 2031. 

A softgel or soft gelatin capsule is a solid capsule (outer shell) surrounding a liquid or semi-solid center (inner fill). An active ingredient can be incorporated into the outer shell, the inner fill, or both. They are oral dosage form for medicine similar to capsules. There are two types of softgel capsules, namely gelatin softgel capsule and vegetarian softgel capsules. Gelatin softgel is usually a single piece of capsule, commonly made of gelatin and consists of liquid or oil-based ingredients. On the other hand, vegetarian softgel capsules are oral dosage of medicines and nutritional supplements delivered in the form of capsules. They are made from starch, pullulan, and cellulose (Hydroxypropyl Methylcellulose).

The growth of global softgel capsules market is majorly driven by increase in demand for softgel capsules owing to rise in number of health-conscious people as well as growth in innovations in the pharmaceutical industry. In addition, rapid development of of e-commerce industry and increase in government expenditure on healthcare are factors responsible for the market growth. 

However, poor demand for softgel capsule in underdeveloped countries and high cost of vegetarian softgel capsules are some restraints that hinders the market growth. On the other hand, high growth potential in emerging markets and growth in vegan population are expected to offer profitable opportunities for the growth of the market during the forecast period.

The softgel capsules market is segmented into type, application, distribution channel, and region. By type, the market is categorized into gelatin softgel capsules and non-gelatin softgel capsules. On the basis of application, the market is segregated into pharmaceuticals, health supplements, and cosmetics. By distribution channel, the market is classified into supermarkets & hypermarkets, pharmacies & drug stores, and online providers. Region-wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

Major key players that operate in the global softgel capsules market are Aenova Group, Best Formulations, Inc., Captek Softgel International, Inc., Catalant, Inc., DCC Plc. (Eurocaps), Procaps Groups, Robinson Pharma, Inc., Lyfe Group (Caps Canada), Sirio Pharma Co. (Ayanda), and Thermofisher Scientific, Inc. (Patheon). 

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the softgel capsule market analysis from 2021 to 2031 to identify the prevailing softgel capsule market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the softgel capsule market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global softgel capsule market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Type

  • Gelatin Softgel Capsules
  • Non-Gelatin softgel Capsules
    • Material
    • Starch
    • Cellulose
    • Pullulan

By Application

  • Pharmaceuticals
  • Health Supplements
  • Cosmetics

By Distribution Channel

  • Supermarkets and Hypermarkets
  • Pharmacies and Drug Stores
  • Online Providers

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest Of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest Of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest Of LAMEA
  • Key Market Players
    • Aenova Group
    • Best Formulations, Inc.
    • Captek Softgel International, Inc.
    • Catalant, Inc.
    • DCC Plc. (Eurocaps)
    • Procaps Groups
    • Robinson Pharma, Inc.
    • Lyfe Group (Caps Canada)
    • Sirio Pharma Co. (Ayanda)
    • Thermofisher Scientific, Inc (Patheon)

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

  • 1.1.Report description
  • 1.2.Key market segments
  • 1.3.Key benefits to the stakeholders
  • 1.4.Research Methodology
    • 1.4.1.Secondary research
    • 1.4.2.Primary research
    • 1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

  • 2.1.Key findings of the study
  • 2.2.CXO Perspective

CHAPTER 3:MARKET OVERVIEW

  • 3.1.Market definition and scope
  • 3.2.Key findings
    • 3.2.1.Top investment pockets
  • 3.3.Porter's five forces analysis
  • 3.4.Top player positioning
  • 3.5.Market dynamics
    • 3.5.1.Drivers
    • 3.5.2.Restraints
    • 3.5.3.Opportunities
  • 3.6.COVID-19 Impact Analysis on the market
  • 3.7.Patent Landscape

CHAPTER 4: SOFTGEL CAPSULES MARKET, BY TYPE

  • 4.1 Overview
    • 4.1.1 Market size and forecast
  • 4.2 Gelatin Softgel Capsules
    • 4.2.1 Key market trends, growth factors and opportunities
    • 4.2.2 Market size and forecast, by region
    • 4.2.3 Market share analysis by country
  • 4.3 Non-Gelatin softgel Capsules
    • 4.3.1 Key market trends, growth factors and opportunities
    • 4.3.2 Market size and forecast, by region
    • 4.3.3 Market share analysis by country
    • 4.3.4 Non-Gelatin softgel Capsules Softgel Capsules Market by Material
      • 4.3.4.1 Starch Market size and forecast, by region
      • 4.3.4.2 Cellulose Market size and forecast, by region
      • 4.3.4.3 Pullulan Market size and forecast, by region

CHAPTER 5: SOFTGEL CAPSULES MARKET, BY APPLICATION

  • 5.1 Overview
    • 5.1.1 Market size and forecast
  • 5.2 Pharmaceuticals
    • 5.2.1 Key market trends, growth factors and opportunities
    • 5.2.2 Market size and forecast, by region
    • 5.2.3 Market share analysis by country
  • 5.3 Health Supplements
    • 5.3.1 Key market trends, growth factors and opportunities
    • 5.3.2 Market size and forecast, by region
    • 5.3.3 Market share analysis by country
  • 5.4 Cosmetics
    • 5.4.1 Key market trends, growth factors and opportunities
    • 5.4.2 Market size and forecast, by region
    • 5.4.3 Market share analysis by country

CHAPTER 6: SOFTGEL CAPSULES MARKET, BY DISTRIBUTION CHANNEL

  • 6.1 Overview
    • 6.1.1 Market size and forecast
  • 6.2 Supermarkets and Hypermarkets
    • 6.2.1 Key market trends, growth factors and opportunities
    • 6.2.2 Market size and forecast, by region
    • 6.2.3 Market share analysis by country
  • 6.3 Pharmacies and Drug Stores
    • 6.3.1 Key market trends, growth factors and opportunities
    • 6.3.2 Market size and forecast, by region
    • 6.3.3 Market share analysis by country
  • 6.4 Online Providers
    • 6.4.1 Key market trends, growth factors and opportunities
    • 6.4.2 Market size and forecast, by region
    • 6.4.3 Market share analysis by country

CHAPTER 7: SOFTGEL CAPSULES MARKET, BY REGION

  • 7.1 Overview
    • 7.1.1 Market size and forecast
  • 7.2 North America
    • 7.2.1 Key trends and opportunities
    • 7.2.2 North America Market size and forecast, by Type
      • 7.2.2.1 North America Non-Gelatin softgel Capsules Softgel Capsules Market by Material
    • 7.2.3 North America Market size and forecast, by Application
    • 7.2.4 North America Market size and forecast, by Distribution Channel
    • 7.2.5 North America Market size and forecast, by country
      • 7.2.5.1 U.S.
      • 7.2.5.1.1 Key market trends, growth factors and opportunities
      • 7.2.5.1.2 Market size and forecast, by Type
      • 7.2.5.1.3 Market size and forecast, by Application
      • 7.2.5.1.4 Market size and forecast, by Distribution Channel
      • 7.2.5.2 Canada
      • 7.2.5.2.1 Key market trends, growth factors and opportunities
      • 7.2.5.2.2 Market size and forecast, by Type
      • 7.2.5.2.3 Market size and forecast, by Application
      • 7.2.5.2.4 Market size and forecast, by Distribution Channel
      • 7.2.5.3 Mexico
      • 7.2.5.3.1 Key market trends, growth factors and opportunities
      • 7.2.5.3.2 Market size and forecast, by Type
      • 7.2.5.3.3 Market size and forecast, by Application
      • 7.2.5.3.4 Market size and forecast, by Distribution Channel
  • 7.3 Europe
    • 7.3.1 Key trends and opportunities
    • 7.3.2 Europe Market size and forecast, by Type
      • 7.3.2.1 Europe Non-Gelatin softgel Capsules Softgel Capsules Market by Material
    • 7.3.3 Europe Market size and forecast, by Application
    • 7.3.4 Europe Market size and forecast, by Distribution Channel
    • 7.3.5 Europe Market size and forecast, by country
      • 7.3.5.1 Germany
      • 7.3.5.1.1 Key market trends, growth factors and opportunities
      • 7.3.5.1.2 Market size and forecast, by Type
      • 7.3.5.1.3 Market size and forecast, by Application
      • 7.3.5.1.4 Market size and forecast, by Distribution Channel
      • 7.3.5.2 France
      • 7.3.5.2.1 Key market trends, growth factors and opportunities
      • 7.3.5.2.2 Market size and forecast, by Type
      • 7.3.5.2.3 Market size and forecast, by Application
      • 7.3.5.2.4 Market size and forecast, by Distribution Channel
      • 7.3.5.3 UK
      • 7.3.5.3.1 Key market trends, growth factors and opportunities
      • 7.3.5.3.2 Market size and forecast, by Type
      • 7.3.5.3.3 Market size and forecast, by Application
      • 7.3.5.3.4 Market size and forecast, by Distribution Channel
      • 7.3.5.4 Italy
      • 7.3.5.4.1 Key market trends, growth factors and opportunities
      • 7.3.5.4.2 Market size and forecast, by Type
      • 7.3.5.4.3 Market size and forecast, by Application
      • 7.3.5.4.4 Market size and forecast, by Distribution Channel
      • 7.3.5.5 Spain
      • 7.3.5.5.1 Key market trends, growth factors and opportunities
      • 7.3.5.5.2 Market size and forecast, by Type
      • 7.3.5.5.3 Market size and forecast, by Application
      • 7.3.5.5.4 Market size and forecast, by Distribution Channel
      • 7.3.5.6 Rest of Europe
      • 7.3.5.6.1 Key market trends, growth factors and opportunities
      • 7.3.5.6.2 Market size and forecast, by Type
      • 7.3.5.6.3 Market size and forecast, by Application
      • 7.3.5.6.4 Market size and forecast, by Distribution Channel
  • 7.4 Asia-Pacific
    • 7.4.1 Key trends and opportunities
    • 7.4.2 Asia-Pacific Market size and forecast, by Type
      • 7.4.2.1 Asia-Pacific Non-Gelatin softgel Capsules Softgel Capsules Market by Material
    • 7.4.3 Asia-Pacific Market size and forecast, by Application
    • 7.4.4 Asia-Pacific Market size and forecast, by Distribution Channel
    • 7.4.5 Asia-Pacific Market size and forecast, by country
      • 7.4.5.1 Japan
      • 7.4.5.1.1 Key market trends, growth factors and opportunities
      • 7.4.5.1.2 Market size and forecast, by Type
      • 7.4.5.1.3 Market size and forecast, by Application
      • 7.4.5.1.4 Market size and forecast, by Distribution Channel
      • 7.4.5.2 China
      • 7.4.5.2.1 Key market trends, growth factors and opportunities
      • 7.4.5.2.2 Market size and forecast, by Type
      • 7.4.5.2.3 Market size and forecast, by Application
      • 7.4.5.2.4 Market size and forecast, by Distribution Channel
      • 7.4.5.3 India
      • 7.4.5.3.1 Key market trends, growth factors and opportunities
      • 7.4.5.3.2 Market size and forecast, by Type
      • 7.4.5.3.3 Market size and forecast, by Application
      • 7.4.5.3.4 Market size and forecast, by Distribution Channel
      • 7.4.5.4 Australia
      • 7.4.5.4.1 Key market trends, growth factors and opportunities
      • 7.4.5.4.2 Market size and forecast, by Type
      • 7.4.5.4.3 Market size and forecast, by Application
      • 7.4.5.4.4 Market size and forecast, by Distribution Channel
      • 7.4.5.5 South Korea
      • 7.4.5.5.1 Key market trends, growth factors and opportunities
      • 7.4.5.5.2 Market size and forecast, by Type
      • 7.4.5.5.3 Market size and forecast, by Application
      • 7.4.5.5.4 Market size and forecast, by Distribution Channel
      • 7.4.5.6 Rest of Asia-Pacific
      • 7.4.5.6.1 Key market trends, growth factors and opportunities
      • 7.4.5.6.2 Market size and forecast, by Type
      • 7.4.5.6.3 Market size and forecast, by Application
      • 7.4.5.6.4 Market size and forecast, by Distribution Channel
  • 7.5 LAMEA
    • 7.5.1 Key trends and opportunities
    • 7.5.2 LAMEA Market size and forecast, by Type
      • 7.5.2.1 LAMEA Non-Gelatin softgel Capsules Softgel Capsules Market by Material
    • 7.5.3 LAMEA Market size and forecast, by Application
    • 7.5.4 LAMEA Market size and forecast, by Distribution Channel
    • 7.5.5 LAMEA Market size and forecast, by country
      • 7.5.5.1 Brazil
      • 7.5.5.1.1 Key market trends, growth factors and opportunities
      • 7.5.5.1.2 Market size and forecast, by Type
      • 7.5.5.1.3 Market size and forecast, by Application
      • 7.5.5.1.4 Market size and forecast, by Distribution Channel
      • 7.5.5.2 Saudi Arabia
      • 7.5.5.2.1 Key market trends, growth factors and opportunities
      • 7.5.5.2.2 Market size and forecast, by Type
      • 7.5.5.2.3 Market size and forecast, by Application
      • 7.5.5.2.4 Market size and forecast, by Distribution Channel
      • 7.5.5.3 South Africa
      • 7.5.5.3.1 Key market trends, growth factors and opportunities
      • 7.5.5.3.2 Market size and forecast, by Type
      • 7.5.5.3.3 Market size and forecast, by Application
      • 7.5.5.3.4 Market size and forecast, by Distribution Channel
      • 7.5.5.4 Rest of LAMEA
      • 7.5.5.4.1 Key market trends, growth factors and opportunities
      • 7.5.5.4.2 Market size and forecast, by Type
      • 7.5.5.4.3 Market size and forecast, by Application
      • 7.5.5.4.4 Market size and forecast, by Distribution Channel

CHAPTER 8: COMPANY LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top winning strategies
  • 8.3. Product Mapping of Top 10 Player
  • 8.4. Competitive Dashboard
  • 8.5. Competitive Heatmap
  • 8.6. Key developments

CHAPTER 9: COMPANY PROFILES

  • 9.1 Aenova Group
    • 9.1.1 Company overview
    • 9.1.2 Company snapshot
    • 9.1.3 Operating business segments
    • 9.1.4 Product portfolio
    • 9.1.5 Business performance
    • 9.1.6 Key strategic moves and developments
  • 9.2 Best Formulations, Inc.
    • 9.2.1 Company overview
    • 9.2.2 Company snapshot
    • 9.2.3 Operating business segments
    • 9.2.4 Product portfolio
    • 9.2.5 Business performance
    • 9.2.6 Key strategic moves and developments
  • 9.3 Captek Softgel International, Inc.
    • 9.3.1 Company overview
    • 9.3.2 Company snapshot
    • 9.3.3 Operating business segments
    • 9.3.4 Product portfolio
    • 9.3.5 Business performance
    • 9.3.6 Key strategic moves and developments
  • 9.4 Catalant, Inc.
    • 9.4.1 Company overview
    • 9.4.2 Company snapshot
    • 9.4.3 Operating business segments
    • 9.4.4 Product portfolio
    • 9.4.5 Business performance
    • 9.4.6 Key strategic moves and developments
  • 9.5 DCC Plc. (Eurocaps)
    • 9.5.1 Company overview
    • 9.5.2 Company snapshot
    • 9.5.3 Operating business segments
    • 9.5.4 Product portfolio
    • 9.5.5 Business performance
    • 9.5.6 Key strategic moves and developments
  • 9.6 Procaps Groups
    • 9.6.1 Company overview
    • 9.6.2 Company snapshot
    • 9.6.3 Operating business segments
    • 9.6.4 Product portfolio
    • 9.6.5 Business performance
    • 9.6.6 Key strategic moves and developments
  • 9.7 Robinson Pharma, Inc.
    • 9.7.1 Company overview
    • 9.7.2 Company snapshot
    • 9.7.3 Operating business segments
    • 9.7.4 Product portfolio
    • 9.7.5 Business performance
    • 9.7.6 Key strategic moves and developments
  • 9.8 Lyfe Group (Caps Canada)
    • 9.8.1 Company overview
    • 9.8.2 Company snapshot
    • 9.8.3 Operating business segments
    • 9.8.4 Product portfolio
    • 9.8.5 Business performance
    • 9.8.6 Key strategic moves and developments
  • 9.9 Sirio Pharma Co. (Ayanda)
    • 9.9.1 Company overview
    • 9.9.2 Company snapshot
    • 9.9.3 Operating business segments
    • 9.9.4 Product portfolio
    • 9.9.5 Business performance
    • 9.9.6 Key strategic moves and developments
  • 9.10 Thermofisher Scientific, Inc (Patheon)
    • 9.10.1 Company overview
    • 9.10.2 Company snapshot
    • 9.10.3 Operating business segments
    • 9.10.4 Product portfolio
    • 9.10.5 Business performance
    • 9.10.6 Key strategic moves and developments
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦